PF-07264660

DRUG2 trials

Sponsors

Pfizer

Conditions

Atopic DermatitisHealthy

Phase 1

A Study to Learn More About the Study Medicine PF-07264660 in Healthy Chinese Adult Participants

CompletedNCT06712082

Start: 2025-02-24End: 2025-09-04Updated: 2025-09-25

Phase 2

A Study To Learn About Two Study Medicines (PF-07275315 And PF-07264660) In People Who Have Moderate To Severe Atopic Dermatitis

RecruitingNCT05995964

PfizerAtopic Dermatitis

Start: 2023-08-22End: 2027-03-08Target: 340Updated: 2026-05-04